SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.
Börse Frankfurt
Börse Börse Frankfurt
Symbol NOVC
EUR
  • Novo Nordisk A/S
    Börse Börse Frankfurt
    Symbol NOVC
    EUR
  • Novo Nordisk A/S
    Börse Börse Frankfurt
    Symbol NOVA
    EUR
  • Novo Nordisk A/S
    Börse Börse München
    Symbol NOVA
    EUR
  • Novo Nordisk A/S
    Börse Börse München
    Symbol NOVC
    EUR
  • Novo Nordisk A/S
    Börse Börse Berlin
    Symbol NOVC
    EUR
  • Novo Nordisk A/S
    Börse Börse Berlin
    Symbol NOVA
    EUR
  • Novo Nordisk A/S
    Börse Börse Düsseldorf
    Symbol NOVA
    EUR
  • Novo Nordisk A/S
    Börse Tradegate System der Deutsche Börse AG (60%)
    Symbol NOVA
    EUR
  • Novo Nordisk A/S
    Börse Quotrix System der Börse Düsseldorf
    Symbol NOVA
    EUR
  • Novo Nordisk A/S
    Börse Börse Stuttgart
    Symbol NOVA
    EUR
  • Novo Nordisk A/S
    Börse Tradegate System der Deutsche Börse AG (60%)
    Symbol NOVC
    EUR
  • Novo Nordisk A/S
    Börse Börse Stuttgart
    Symbol NOVC
    EUR
  • Novo Nordisk A/S
    Börse Gettex System der Börse München
    Symbol NOVC
    EUR
  • Novo Nordisk A/S
    Börse Quotrix System der Börse Düsseldorf
    Symbol NOVC
    EUR
  • Novo Nordisk A/S
    Börse Börse Düsseldorf
    Symbol NOVC
    EUR
  • Novo Nordisk A/S
    Börse Gettex System der Börse München
    Symbol NOVA
    EUR
  • Novo Nordisk A/S
    Börse Börse Stuttgart
  • Novo Nordisk A/S
    Börse Börse Stuttgart
  • Novo Nordisk A/S ADR
    Börse NYSE New York Stock Exchange
    ISIN US6701002056 WKN: 866931
    Symbol NVO
  • NOVO NORDISK A/S-B
    Börse Amerikanscher Freiverkehr OTC oder "Pink Sheets"
    ISIN DK0060534915 WKN: A1XA8R
    Symbol NOVOB
    USD
  • Novo Nordisk A/S B
    Börse NYSE New York Stock Exchange
    ISIN DK0060534915 WKN: A1XA8R
    Symbol NOVO-B
    EUR
  • NOVO NORDISK A/S-B
    Börse Amerikanscher Freiverkehr OTC oder "Pink Sheets"
    Symbol NOVC
    USD
  • Novo Nordisk A/S B
    Börse OMXC Copenhagen Stock Exchange
    ISIN DK0060534915 WKN: A1XA8R
    Symbol NOVO B
  • ISIN DK0060534915
  • MXN
  • Symbol NOVC
  • Symbol NOVA
  • Novo Nordisk
    Börse London Stock Exchange
  • Novo Nordisk A/S
    Börse Freiverkehr OTC
Symbol NOVC
Währung EUR
Börse Börse Frankfurt

Novo Nordisk outperformed den DAX um +67 % vom 30.09.2013 bis 08.05.2015

Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von

Analystenmeinungen

Übersicht

84 News & Informationen zur Novo Nordisk Aktie

  • Futures Rise Ahead Of Claims Data; Europe Hits Another Record High
    zerohedge.com

    Futures Rise Ahead Of Claims Data; Europe Hits Another Record High

    ZeroHedge – On a long enough timeline, the survival rate for everyone drops to zero

  • 3 High Ebitda Margin Ratio Stock Picks
    gurufocus.com

    3 High Ebitda Margin Ratio Stock Picks

    GuruFocus Article or News written by Alberto Abaterusso and the topic is about: These businesses appear to be in a good shape from a financial standpoint

  • 15 Most Valuable Biotech Companies in the World
    insidermonkey.com

    15 Most Valuable Biotech Companies in the World

    In this article we will take a look at the 15 most valuable biotech companies in the world. You can skip our detailed analysis of the biotechnology industry…

  • Dicerna Announces FDA Clearance Of Investigational New Drug (IND) Application For DCR-AUD For The Treatment Of Alcohol Use Disorder
    thestreet.com

    Dicerna Announces FDA Clearance Of Investigational New Drug (IND) Application For DCR-AUD For The Treatment Of Alcohol Use Disorder

    Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) (“Company” or “Dicerna”), a leading developer of investigational ribonucleic acid interference (RNAi)

  • Continuous Glucose Monitoring Device Market Size Worth $10.36 Billion By 2028: Grand View Research, Inc.
    markets.businessinsider.com

    Continuous Glucose Monitoring Device Market Size Worth $10.36 Billion By 2028: Grand View Research, Inc.

    SAN FRANCISCO, July 29, 2021 /PRNewswire/ — The global continuous glucose monitoring device market size is expected to reach USD 10.36 billion by…

  • Continuous Glucose Monitoring Device Market Size Worth $10.36 Billion By 2028: Grand View Research, Inc.
    thestreet.com

    Continuous Glucose Monitoring Device Market Size Worth $10.36 Billion By 2028: Grand View Research, Inc.

    SAN FRANCISCO, July 29, 2021 /PRNewswire/ — The global continuous glucose monitoring device market size is expected  to reach USD 10.36 billion by 2028,

  • Novo Holdings Leads US$ 118M Series C Investment in Genomatica
    markets.businessinsider.com

    Novo Holdings Leads US$ 118M Series C Investment in Genomatica

    – Financing to amplify the scale and impact of Genomatica's sustainable materials- Underscores Novo Holdings' commitment to support the developmen…

  • First National Bank of Hutchinson Buys iShares 0-5 Year TIPS Bond ETF, MasTec Inc, MYR Group Inc, Sells BTC iShares International Select...
    gurufocus.com

    First National Bank of Hutchinson Buys iShares 0-5 Year TIPS Bond ETF, MasTec Inc, MYR Group Inc, Sells BTC iShares International Select Dividend ETF, iShares iBoxx USD Investment Grade Corporate Bond

    GuruFocus Article or News written by insider and the topic is about:

  • KCS Wealth Advisory Buys iShares Investment Grade Bond Factor ETF, Vanguard Short-Term Government Bond ETF, Alibaba Group Holding, Sells...
    gurufocus.com

    KCS Wealth Advisory Buys iShares Investment Grade Bond Factor ETF, Vanguard Short-Term Government Bond ETF, Alibaba Group Holding, Sells International Paper Co, Owens-Corning Inc, M/I Homes Inc

    GuruFocus Article or News written by insider and the topic is about:

  • Were Hedge Funds Right About BHP Group (BHP)?
    insidermonkey.com

    Were Hedge Funds Right About BHP Group (BHP)?

    In this article you are going to find out whether hedge funds think BHP Group (NYSE:BHP) is a good investment right now. We like to check what the smart…

  • 10 Most Valuable Companies in Europe
    insidermonkey.com

    10 Most Valuable Companies in Europe

    In this article we will take a look at the 10 most valuable companies in Europe. However, you can skip our detailed analysis of these European companies…

  • Alliance Trust PLC - Half Year Results
    globenewswire.com

    Alliance Trust PLC – Half Year Results

    Strong performance in H1:2021 Results for six months ended 30 June 2021 Financial highlights  As at 6 months to 30 June 2021As at 12 months to 31 Dec…

  • Worldwide Rapid Acting Insulin Industry to 2027 - Players Include Merck & Co, Sanofi and Novo Nordisk Among Others
    prnewswire.com

    Worldwide Rapid Acting Insulin Industry to 2027 – Players Include Merck & Co, Sanofi and Novo Nordisk Among Others

    /PRNewswire/ — The “Global Rapid Acting Insulin Market By Product Type, By Indication, By Distribution Channel, By Regional Outlook, Industry Analysis Report…

  • Worldwide Rapid Acting Insulin Industry To 2027 - Players Include Merck & Co, Sanofi And Novo Nordisk Among Others
    thestreet.com

    Worldwide Rapid Acting Insulin Industry To 2027 – Players Include Merck & Co, Sanofi And Novo Nordisk Among Others

    DUBLIN, July 22, 2021 /PRNewswire/ — The “Global Rapid Acting Insulin Market By Product Type, By Indication, By Distribution Channel, By Regional Outlook,

  • Novo Holdings co-leads Hemab's US$ 55M Series A to Advance Next Generation Therapeutics for Bleeding and Thrombosis Disorders
    prnewswire.com

    Novo Holdings co-leads Hemab's US$ 55M Series A to Advance Next Generation Therapeutics for Bleeding and Thrombosis Disorders

    /PRNewswire/ — Novo Holdings, a leading international life science investor, today announces that it has co-led alongside HealthCap and RA Capital Management…

  • Hemab Raises US$ 55M Series A to Advance Next Generation Therapeutics for Bleeding and Thrombosis Disorders
    markets.businessinsider.com

    Hemab Raises US$ 55M Series A to Advance Next Generation Therapeutics for Bleeding and Thrombosis Disorders

    COPENHAGEN, Denmark and BOSTON, July 22, 2021 /PRNewswire/ — Hemab ApS ('Hemab'), a biotech company developing next generation therapeutics for s…

  • Dicerna Announces Interim Results From Phase 1 Trial Of Belcesiran For Treatment Of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease
    thestreet.com

    Dicerna Announces Interim Results From Phase 1 Trial Of Belcesiran For Treatment Of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease

    Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) (the “Company” or “Dicerna”), a leading developer of investigational ribonucleic acid interference (RNAi)

  • Worldwide Diabetes Devices and Drugs Industry to 2026 - Featuring Novo Nordisk, Ypsomed and Abbott Laboratories Among Others
    prnewswire.com

    Worldwide Diabetes Devices and Drugs Industry to 2026 – Featuring Novo Nordisk, Ypsomed and Abbott Laboratories Among Others

    /PRNewswire/ — The “Diabetes Devices and Drugs Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2026” report has been added to…

  • Global Generic Drugs Market To Reach $507.8 Billion By 2026
    thestreet.com

    Global Generic Drugs Market To Reach $507.8 Billion By 2026

    SAN FRANCISCO, July 14, 2021  /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today

  • Global Generic Drugs Market to Reach $507.8 Billion by 2026
    prnewswire.com

    Global Generic Drugs Market to Reach $507.8 Billion by 2026

    /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled…

  • Catalyst Biosciences Announces Key Leadership Changes In Its Ongoing Transition To An Integrated Protease Medicines Company
    thestreet.com

    Catalyst Biosciences Announces Key Leadership Changes In Its Ongoing Transition To An Integrated Protease Medicines Company

    Grant Blouse, Ph.D., M.Sc. appointed chief scientific officer
    Tom Knudsen, DVM, Ph.D. promoted to senior vice president, corporate development
    Howard

  • Global Human Growth Hormone Drugs Market to Reach $4 Billion by 2026
    prnewswire.com

    Global Human Growth Hormone Drugs Market to Reach $4 Billion by 2026

    /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled…

  • Mid-Afternoon Market Update: Dow Surges Over 100 Points; State Auto Financial Shares Jump
    markets.businessinsider.com

    Mid-Afternoon Market Update: Dow Surges Over 100 Points; State Auto Financial Shares Jump

    Toward the end of trading Monday, the Dow traded up 0.34% to 34,987.02 while the NASDAQ rose 0.08% to 14,713.30. The S&P also rose, gaining 0….

  • Prothena And Novo Nordisk Announce Acquisition Agreement For Prothena's ATTR Amyloidosis Programme
    thestreet.com

    Prothena And Novo Nordisk Announce Acquisition Agreement For Prothena's ATTR Amyloidosis Programme

    Prothena is eligible to receive development and sales milestone payments totalling up to 1.2 billion US dollars, including 100 million dollars in upfront and

  • Novo Nordisk A/S Stock Gives Every Indication Of Being Modestly Overvalued
    gurufocus.com

    Novo Nordisk A/S Stock Gives Every Indication Of Being Modestly Overvalued

    GuruFocus Article or News written by GF Value and the topic is about:

  • Novo Holdings Launches Muna Therapeutics with US$ 73M Series A to Advance Novel Small Molecule Therapeutics for Neurodegenerative Diseases
    markets.businessinsider.com

    Novo Holdings Launches Muna Therapeutics with US$ 73M Series A to Advance Novel Small Molecule Therapeutics for Neurodegenerative Diseases

    COPENHAGEN, Denmark, July 9, 2021 /PRNewswire/ — Novo Holdings, a global life science investor, today announces that it has co-led the Series A f…

  • Muna Therapeutics Launches With US$ 73M Series A To Advance Novel Small Molecule Therapeutics For Neurodegenerative Diseases
    thestreet.com

    Muna Therapeutics Launches With US$ 73M Series A To Advance Novel Small Molecule Therapeutics For Neurodegenerative Diseases

    COPENHAGEN, Denmark, July 9, 2021 /PRNewswire/ — Muna Therapeutics (“Muna”), pioneering the development of first-in-class small molecule therapeutics for

  • Novo Holdings Launches Muna Therapeutics with US$ 73M Series A to Advance Novel Small Molecule Therapeutics for Neurodegenerative Diseases
    prnewswire.com

    Novo Holdings Launches Muna Therapeutics with US$ 73M Series A to Advance Novel Small Molecule Therapeutics for Neurodegenerative Diseases

    /PRNewswire/ — Novo Holdings, a global life science investor, today announces that it has co-led the Series A financing of its portfolio company, Muna…

  • Renaissance Investment Group LLC Buys 3M Co, Novozymes A/S, iShares Russell Mid-Cap Growth ETF, Sells American Tower Corp, The Walt Disney...
    gurufocus.com

    Renaissance Investment Group LLC Buys 3M Co, Novozymes A/S, iShares Russell Mid-Cap Growth ETF, Sells American Tower Corp, The Walt Disney Co, General Electric Co

    GuruFocus Article or News written by insider and the topic is about:

  • Forget Senseonics, Buy These 3 Diabetes Stocks Instead By StockNews
    investing.com

    Forget Senseonics, Buy These 3 Diabetes Stocks Instead By StockNews

    Forget Senseonics, Buy These 3 Diabetes Stocks Instead

  • These Are The Top Ten Picks Of Jim Simons
    valuewalk.com

    These Are The Top Ten Picks Of Jim Simons

    We have referred to the latest available 13F filing to come up with the top ten picks of Jim Simons. Novo Nordisk tops the list.

  • These Are The Top Ten Picks Of Jim Simons
    entrepreneur.com

    These Are The Top Ten Picks Of Jim Simons

    Jim Simons is one of the greatest investors of all time and is known as the “Quant King.” He founded one of the most successful quant fund…

  • Dicerna Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    thestreet.com

    Dicerna Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) (the “Company” or “Dicerna”), a leading developer of investigational ribonucleic acid interference (RNAi)

  • Denmark stocks lower at close of trade; OMX Copenhagen 20 down 0.05% By Investing.com
    investing.com

    Denmark stocks lower at close of trade; OMX Copenhagen 20 down 0.05% By Investing.com

    Denmark stocks lower at close of trade; OMX Copenhagen 20 down 0.05%

  • Industrial Enzymes Market to Grow Significantly at 6.3% CAGR from 2020 to 2027 - Report by Market Research Future (MRFR)
    globenewswire.com

    Industrial Enzymes Market to Grow Significantly at 6.3% CAGR from 2020 to 2027 – Report by Market Research Future (MRFR)

    Industrial Enzymes Market Insights and Industry Analysis by Type (Carbohydrases [Amylase, Glucanase, Cellulase and others], Proteases, Lipases and others),…

  • Rising Diabetic Patients Pool Prompts High Demand for Smart Insulin Pens, Market Estimated to be valued at US$ 70.4 Mn by 2027 End: TMR
    prnewswire.com

    Rising Diabetic Patients Pool Prompts High Demand for Smart Insulin Pens, Market Estimated to be valued at US$ 70.4 Mn by 2027 End: TMR

    /PRNewswire/ — Smart insulin refers to advanced insulin that is capable to respond automatically to varying blood glucose levels. Thus, higher or lower blood…

  • Novo Nordisk A S (NVO): Price Now Near $72.19; Daily Chart Shows Downtrend on 50 Day Basis
    etfdailynews.com

  • Global Hematology Drugs Market (2021 to 2030) - COVID-19 Impact and Recovery
    prnewswire.com

  • Magic Software Enterprises steigert Dividende ...
    mydividends.de

    Magic Software Enterprises steigert Dividende

    Magic Software Enterprises Ltd. (ISIN: IL0010823123, NASDAQ: MGIC) kündigt eine Halbjahresdividende in Höhe von 0,21 US-Dollar je Aktie an und steigert damit die Dividendenausschüttung um 20 Prozent, wie der Konzern am Montag mitteilte. Die Auszahlung erfolgt am 7. April 2021 (Record date: 25. März 2021). Die aktuelle Dividendenrendite liegt damit beim derzeitigen Aktienkurs von 16,08 US-Dollar (Stand: 8. März 2021)

  • Casey’s General Stores meldet Dividende ...
    mydividends.de

    Casey’s General Stores meldet Dividende

    Die US-Einzelhandelskette Casey’s General Stores Inc. (ISIN: US1475281036, NASDAQ: CASY) wird eine Quartalsdividende in Höhe von 34 US-Cents je Aktie an ihre Anteilseigner ausschütten, wie am Montag berichtet wurde. Die Auszahlung der Dividende erfolgt am 17. Mai 2021 (Record date ist der 3. Mai 2021). Auf das Jahr hochgerechnet erhalten die Aktionäre 1,36 US-Dollar. Beim aktuellen Kursniveau von 202,21 US-Dollar

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

Portrait der Novo Nordisk Aktie

Das Unternehmen Novo Nordisk aus Dänemark ist in den Bereichen Chemie & Pharma, Einzelhandel (Medikamente), Einzelhandel, Pharma tätig.

Die Novo Nordisk Aktie konnte seit dem 30.09.2013 eine Rendite von 101% erwirtschaften.

Novo Nordisk ist in mehr als 64 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter iShares STOXX Europe 600 Health Care  UCITS  ETF (DE) gewichtet Novo Nordisk mit 9,30% im ETF.

Entdecke die 6 ETFs in denen Novo Nordisk am höchsten gewichtet ist Insgesamt in 64 ETFs enthalten

Dir gefallen die Informationen zu Novo Nordisk?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero

Dir gefallen die Informationen zu Novo Nordisk?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba

Dir gefallen die Informationen zu Novo Nordisk?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic

Dir gefallen die Informationen zu Novo Nordisk?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect